AGIO

Agios Pharmaceuticals Inc. Common Stock (AGIO)

Stock · NASDAQ · Health Care

$33.32as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$27.71
Industry
Biotechnology: Pharmaceutical Preparations

Agios Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • AGIO
    Agios Pharmaceuticals Inc. Common Stock
    $33.32
    ▼ 2.80%
    Market cap $1.82BP/E
  • GENB
    Generate Biomedicines Inc. Common Stock
    $15.33
    ▼ 2.79%
    Market cap $1.84BP/E
    $11$22.67
  • OCUL
    Ocular Therapeutix Inc. Common Stock
    $10.36
    ▼ 4.25%
    Market cap $1.84BP/E
    $6.23$16.44
  • STOK
    Stoke Therapeutics Inc. Common Stock
    $31.61
    ▼ 3.01%
    Market cap $1.84BP/E
    $18.8$40.22
  • ANIP
    ANI Pharmaceuticals Inc.
    $72.83
    ▼ 0.93%
    Market cap $1.80BP/E 18.72
    $70.15$99.5
  • URGN
    UroGen Pharma Ltd. Ordinary Shares
    $43.61
    ▼ 4.15%
    Market cap $1.88BP/E
    $15.86$50.81
  • NBTX
    Nanobiotix S.A. American Depositary Shares
    $41.28
    ▼ 8.59%
    Market cap $1.88BP/E
    $7.02$47.66

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
63.79M
Total value held
$2.02B
Institutional holders
227
Top holders this quarter
  • Unknown5.92M
  • Unknown5.75M
  • Unknown5.68M
  • Unknown3.36M
  • Unknown2.70M
  • Unknown2.68M
  • Unknown2.63M
  • Unknown2.61M
  • Unknown1.58M
  • Unknown1.56M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.